BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023)

BioCorRx's (BICX) quarterly Asset Writedowns and Impairment came in at $47980.0 in Q1 2023, up 1311.18% quarter-over-quarter from $3400.0 in Q2 2019.

BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023) Analysis & Trends

BioCorRx has disclosed Asset Writedowns and Impairment across 6 years of filings, most recently posting $47980.0 for Q1 2023.

  • Asset Writedowns and Impairment for Q1 2023 came in at $47980.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $47980.0 (changed N/A YoY), and the FY2023 annual result was $47980.0, changed N/A from the prior year.
  • Asset Writedowns and Impairment came in at $47980.0 for Q1 2023 at BioCorRx, up from $3400.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $47980.0 in Q1 2023 to a low of -$1000.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn
10 BioCorRx - - 189,355.00

Historic Data

Download Data
DateValue
Mar 31, 2023 47,980.00
Mar 31, 2023 47,980.00
Jun 30, 2019 3,400.00
Jun 30, 2019 3,400.00
Mar 31, 2019 -1,000.00
Mar 31, 2019 -1,000.00
Dec 31, 2018 234,250.00
Dec 31, 2018 234,250.00
Sep 30, 2018 3,500.00
Sep 30, 2018 3,500.00
Jun 30, 2018 -3,500.00
Jun 30, 2018 -3,500.00
Mar 31, 2018 15,750.00
Mar 31, 2018 15,750.00
Dec 31, 2017 5,375.00
Dec 31, 2017 5,375.00
Dec 31, 2016 51,000.00
Dec 31, 2016 51,000.00
Jun 30, 2016 6,000.00
Jun 30, 2016 6,000.00